Association of the novel serologic anti-glycan antibodies anti-laminarin and anti-chitin with complicated Crohnʼs disease behavior
Abstract
BACKGROUND: We tested a panel of novel serological anti-glycan antibodies including the previously unpublished anti-laminarin IgA (Anti-L) and anti-chitin IgA (Anti-C) carbohydrate antibodies for the presence in Crohn's disease (CD) patients, diagnosis and differentiation of CD, association with complicated disease behavior, and marker stability over time. METHODS: The presence of Anti-L, Anti-C, anti-chitobioside IgA (ACCA), anti-laminaribioside IgG (ALCA), anti-mannobioside IgG (AMCA), and anti-Saccaromyces cervisiae IgG (gASCA) carbohydrate antibodies were tested in serum samples from 824 participants (363 CD, 130 ulcerative colitis [UC], 74 other gastrointestinal diseases, and 257 noninflammatory bowel/gastrointestinal disease controls) of the German IBD-network by enzyme-linked immunosorbent assay (ELISA; Glycominds, Lod, Israel) and for perinuclear antineutrophil cytoplasmic antibody (pANCA) by immunofluorescence. RESULTS: In all, 77.4% of the CD patients were positive for at least 1 of the anti-glycan antibodies. gASCA or the combination of gASCA/pANCA remained most accurate for the diagnosis of CD, but the combined use of the antibodies improved differentiation of CD from UC. Several single markers as well as an increasing antibody response were independently linked to a severe disease phenotype, as shown for the occurrence of complications, CD-related surgery, early disease onset, and ileal disease location. This was observed for both quantitative and qualitative antibody responses. The antibody status remained stable over time in most IBD patients. CONCLUSIONS: A panel of anti-glycan antibodies including the novel Anti-L and Anti-C may aid in differentiation of CD from UC, is associated with complicated CD behavior and IBD-related surgery, and is stable over time in a large patient cohort.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In intestinal mesenchymal cells, a pro-fibrogenic phenotype was triggered exclusively by flagellin, a TLR5 ligand, in a TGF-β1-independent manner and via post-transcriptional regulation.
“although intestinal mesenchymal cells express multiple TLRs and NLRs, a pro-fibrogenic phenotype was triggered exclusively by flagellin, a broad activator of innate and adaptive immunity and a TLR5 ligand. This occurred in a TGF-β1 independent manner and via post-transcriptional regulation160”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [160]
Selective deletion of MyD88 in αSMA-positive cells ameliorated intestinal fibrosis.
“selective deletion of MyD88 in αSMA positive cells ameliorated intestinal fibrosis160”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [160]
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649 · see citing works
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591 · see citing works
Unravelling the pathogenesis of inflammatory bowel disease
Xavier, R. J., & Podolsky, D. K. (2007) · Nature · doi:10.1038/nature06005 · Cited by 4,364 · see citing works
Silverberg, M. S., Satsangi, J., Ahmad, T., Arnott, I. D., Bernstein, C. N., Brant, S. R., Caprilli, R., Colombel, J., Gasché, C., Geboes, K., et al. (2005) · Canadian Journal of Gastroenterology · doi:10.1155/2005/269076 · Cited by 3,408 · see citing works
Microbial Influences in Inflammatory Bowel Diseases
Sartor, R. B. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.059 · Cited by 1,927 · see citing works
Hampe, J., Franke, A., Rosenstiel, P. C., Till, A., Teuber, M., Huse, K., Albrecht, M., Gabriele Mayr, B., Vega, F. M. D. L., Briggs, J. C., et al. (2006) · Nature Genetics · doi:10.1038/ng1954 · Cited by 1,899 · see citing works
Assche, G. V., Dignass, A. U., Panés, J., Beaugerie, L., Karagiannis, J. A., Allez, M., Ochsenkühn, T., Orchard, T., Rogler, G., Louis, E. J., et al. (2010) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2009.12.003 · Cited by 1,444 · see citing works
Self-citationGasché, C., Schölmerich, J., Brynskov, J., D’Haens, G., Hanauer, S. B., Irvine, J. E., Jewell, D. P., Rachmilewitz, D., Sachar, D. B., Sandborn, W. J., et al. (2000) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200002000-00002 · Cited by 1,135 · see citing works
D’Haens, G., Geboes, K., Peeters, M., Baert, F., PENNINCKX, F. M., & Rutgeerts, P. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70476-7 · Cited by 866 · see citing works
Bacterial flagellin is a dominant antigen in Crohn disease
Lodes, M. J., Cong, Y., Elson, C. O., Mohamath, R., Landers, C. J., Targan, S. R., Fort, M., & Hershberg, R. M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420295 · Cited by 802 · see citing works
Clinical Course in Crohn’s Disease: Results of a Norwegian Population-Based Ten-Year Follow-Up Study
Solberg, I. C., Vatn, M. H., Høie, O., Stray, N., Sauar, J., Jahnsen, J., Moum, B. A., & Lygren, I. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.09.002 · Cited by 697 · see citing works
Cosnes, J., Nion–Larmurier, I., Beaugerie, L., Afchain, P., Tiret, E., & Jp, G. (2005) · Gut · doi:10.1136/gut.2004.045294 · Cited by 655 · see citing works
Franchimont, D. P., Vermeire, S., Housni, H. E., Pierik, M. J., Steen, K. V., Gustot, T., Quertinmont, E., Abramowicz, M., Gossum, A. V., Devière, J., et al. (2004) · Gut · doi:10.1136/gut.2003.030205 · Cited by 596 · see citing works
Stange, E. F., Travis, S. P. L., Vermeire, S., Reinisch, W., Geboes, K., Barakauskienė, A., Feakins, R. M., Fléjou, J., Herfarth, H. H., Hommes, D. W., et al. (2008) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2007.11.001 · Cited by 551 · see citing works
Mow, W. S., Vasiliauskas, E. A., Lin, Y.-C., Fleshner, P. R., Papadakis, K. A., Taylor, K. D., Landers, C. J., Abreu-Martin, M. T., Rotter, J. I., Yang, H., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.015 · Cited by 517 · see citing works
Targan, S. R., Landers, C. J., Yang, H., Lodes, M. J., Cong, Y., Papadakis, K. A., Vasiliauskas, E., Elson, C. O., & Hershberg, R. M. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.046 · Cited by 476 · see citing works
Landers, C. J., Cohavy, O., Misra, R., Yang, H., Lin, Y., Braun, J. G., & Targan, S. R. (2002) · Gastroenterology · doi:10.1053/gast.2002.35379 · Cited by 440 · see citing works
Long-term follow-up of patients with Crohn's disease
Ricketts, R. R. (1986) · Journal of Pediatric Surgery · doi:10.1016/s0022-3468(86)80458-4 · Cited by 397 · see citing works
Peeters, M., Joossens, S. B. A., Vermeire, S., VLIETINCK, R. F., Bossuyt, X., & Rutgeerts, P. J. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)02406-0 · Cited by 341 · see citing works
Vasiliauskas, E. A., Kam, L. Y., Karp, L. C., et al. (2000) · Gut · doi:10.1136/gut.47.4.487 · Cited by 314 · see citing works
Peeters, M., Joossens, S. B. A., Vermeire, S. A. R. A., et al. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03613.x · Cited by 301 · see citing works
Ferrante, M., Henckaerts, L., Joossens, M., Pierik, M. J., Joossens, S. B. A., Dotan, N., Norman, G. L., Altstock, R. T., Steen, K. V., Rutgeerts, P., et al. (2007) · Gut · doi:10.1136/gut.2006.108043 · Cited by 292 · see citing works
Self-citationEPIDEMIOLOGY AND THE NATURAL COURSE OF INFLAMMATORY BOWEL DISEASE
Andres, P. G., & Friedman, L. S. (1999) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(05)70056-x · Cited by 284 · see citing works
Pierik, M. J., Joossens, S. B. A., Steen, K. V., Schuerbeek, N. V., VLIETINCK, R. F., Rutgeerts, P., & Vermeire, S. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000195389.11645.ab · Cited by 280 · see citing works
Increased Immune Reactivity Predicts Aggressive Complicating Crohn's Disease in Children
Dubinsky, M. C., Kugathasan, S., Mei, L., Picornell, Y., Nebel, J., Wrobel, I. T., Quiros, A., Silber, G. H., Wahbeh, G. T., Katzir, L., et al. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.04.032 · Cited by 245 · see citing works
Phenotype at diagnosis predicts recurrence rates in Crohn’s disease
Wolters, F. J., Rüssel, M. G., Sijbrandij, J., Ambergen, T., Odes, S., Riis, L., Langholz, E., Politi, P., Qasim, A., Κoutroubakis, I. E., et al. (2005) · Gut · doi:10.1136/gut.2005.084061 · Cited by 235 · see citing works
Antibodies Against Laminaribioside and Chitobioside Are Novel Serologic Markers in Crohn’s Disease
Dotan, I., Fishman, S., Dgani, Y., Schwartz, M., Karban, A. A., Lerner, A., Weisshaus, O., Spector, L., Shtevi, A., Altstock, R. T., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.04.030 · Cited by 233 · see citing works
Self-citationArnott, I. D., Landers, C. J., Nimmo, E., Drummond, H. E., Smith, B., Targan, S. R., & Satsangi, J. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.40417.x · Cited by 230 · see citing works
Are Perineal and Luminal Fistulas Associated in Crohn’s Disease? A Population-Based Study
Tang, L., Rawsthorne, P. E., & Bernstein, C. N. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.06.021 · Cited by 171 · see citing works
Papp, M., Altorjay, I., Dotan, N., et al. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01652.x · Cited by 148 · see citing works
Self-citationSutton, C. L., Yang, H., Li, Z., Rotter, J. I., Targan, S. R., & Braun, J. (2000) · Gut · doi:10.1136/gut.46.1.58 · Cited by 146 · see citing works
Amre, D. K., Lu, S., Costea, F., & Seidman, E. G. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00468.x · Cited by 126 · see citing works
Smith, B., Arnott, I. D., Drummond, H. E., Nimmo, E. R., & Satsangi, J. (2004) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200409000-00005 · Cited by 94 · see citing works
Κoutroubakis, I. E., Petinaki, E. A., Mouzas, I., et al. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03524.x · Cited by 82 · see citing works
Is Perianal Crohn's Disease Associated with Intestinal Fistulization?
Sachar, D. B., Bodian, C., Goldstein, E. S., et al. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.40980.x · Cited by 76 · see citing works
The Utility of ANCA and ASCA in Inflammatory Bowel Disease
Targan, S. R. (1999) · Inflammatory Bowel Diseases · doi:10.1097/00054725-199902000-00008 · Cited by 56 · see citing works
Evolution of clinical behaviour in Crohn's disease: predictive factors of penetrating complications
Papi, C., Festa, V. M., Fagnani, C., et al. (2005) · Digestive and Liver Disease · doi:10.1016/j.dld.2004.10.012 · Cited by 54 · see citing works
Devlin, S. M., & Dubinsky, M. C. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20292 · Cited by 14 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Fibrosis: from mechanisms to medicines
Henderson, N. C., Rieder, F., & Wynn, T. A. (2020) · Nature · doi:10.1038/s41586-020-2938-9 · Cited by 1,868 · see citing works
Self-citationBiomarkers in inflammatory bowel disease: current practices and recent advances.
Iskandar, H. N., & Ciorba, M. A. (2012) · Translational Research · doi:10.1016/j.trsl.2012.01.001 · Cited by 210 · see citing works
Serum anti-glycan antibodies predict complicated Crohnʼs disease behavior: A cohort study†
Rieder, F., Schleder, S., Wolf, A., Dirmeier, A., Strauch, U., Obermeier, F., Lopez, R., Spector, L., Fire, E., Yarden, J., et al. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21179 · Cited by 84 · see citing works
Self-citation
- Authors
- Rieder, F., Schleder, S., Wolf, A., Dirmeier, A., Strauch, U., Obermeier, F., Lopez, R., Spector, L., Fire, E., Yarden, J., Rogler, G., Dotan, N., & Klebl, F.
- Affiliations
- University of Regensburg (DE)
- Cleveland Clinic (US)
- University Hospital Zurich (CH)
- Venue
- Inflammatory Bowel Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-02
- Volume
- 16
- Issue
- 2
- Pages
- 263-274
- ISSN
- 1078-0998 (ISSN-L)
- OpenAlex
- W2105810938
- Cited by
- 101
- References
- 38
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 2 · 2023: 5 · 2022: 1 · 2021: 6 · 2020: 8 · 2019: 4 · 2018: 2 · 2017: 2 · 2016: 11 · 2015: 10 · 2014: 9 · 2013: 7 · 2012: 12
- FWCI
- 5.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Inflammatory Bowel Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Health Sciences › Medicine › Epidemiology › Autoimmune and Inflammatory Disorders
- Keywords
- Crohn's disease, anti-glycan antibodies
- MeSH terms
- Adult, Age Factors, Autoantibodies, Chitin, Crohn Disease, Female, Glucans, Humans, Male, Polysaccharides, ROC Curve, Severity of Illness Index, Biomarkers, Disease Progression, Fluorescent Antibody Technique, Indirect
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
